Singapore accelerates integration of AI-powered solutions into clinical care

ASUS and Tan Tock Seng Hospital (TTSH) have inked a three-year Memorandum of Understanding (MoU) to formalise ...

July 7, 2022 | Thursday | News
“Spending on TB control programmes had dropped to 2016 levels in 2020 and remains unchanged”

How is QIAGEN helping to reduce the growing burden of TB in APAC? QIAGEN promotes TB prevention (Test and Treat strateg...

June 30, 2022 | Thursday | Opinion
Seegene develops PCR test to detect monkeypox virus

Seegene Inc., South Korea-based molecular diagnostics (MDx) company, has developed a PCR test to detect the mo...

June 29, 2022 | Wednesday | News
JOYSBIO develops antigen rapid test to detect Omicron subvariants BA.4 and BA.5

As the SARS-COV-2 Omicron subvariants BA.4 and BA.5 make their way across the EU and the US, China-based Joysbio has dev...

June 27, 2022 | Monday | News
Ainos COVID-19 antigen self-test receives approval for sale in Taiwan

US-based Ainos, a diversified medtech company focused on the development of novel point-of-care testing, low-dose interf...

June 24, 2022 | Friday | News
Japan-based Fujirebio acquires ADx Neurosciences for €40 M

Japan's H.U. Group Holdings Inc., and its wholly-owned subsidiary Fujirebio Holdings, Inc., and Belgium-based ADx NeuroS...

June 24, 2022 | Friday | News
South Korea approves Agilent's diagnostic platform to identify NSCLC patients

South Korea Ministry of Food and Drug Safety (MFDS) has approved the Agilent Technologies PD-L1 IHC 22C3 pharmDx as a co...

June 15, 2022 | Wednesday | News
Exploring untapped potentials at the Asia-Pacific digital pathology market

The synergy of AI and digital pathology has opened a world of image-based possibilities that can transform disease diagn...

June 14, 2022 | Tuesday | Opinion
Health tech firm Annalise partners with Fujifilm Australia

Sydney based Healthcare AI firm annalise.ai has partnered with Fujifilm Australia for the distribution of its decision s...

June 8, 2022 | Wednesday | News
Singapore's Us2.ai expands multi-modality echocardiography AI analytics reach

Us2.ai, a Singapore-based medtech firm has received CE Mark clearance for Us2.v1, a completely automated decision suppor...

June 8, 2022 | Wednesday | News
Parse Biosciences inks pact with Molecular Diagnostics Korea

US-based Parse Biosciences, a leading provider of scalable single-cell sequencing solutions, has announced a partnership...

June 7, 2022 | Tuesday | News
MiRXES opens Southeast Asia’s first industry 4.0 IVD manufacturing facility

MiRXES Pte Ltd, a Singapore-headquartered biotechnology company, and A*STAR spinoff, focused on s...

May 30, 2022 | Monday | News
Seegene unveils '$12 PCR testing' initiative to help end COVID-19 pandemic

Seegene Inc., South Korea's leading molecular diagnostics (MDx) company, has unveiled a global initiative for ...

May 26, 2022 | Thursday | News
New Horizon Health partners with Prenetics to launch non-invasive colon cancer test

New Horizon Health and Prenetics has announced a strategic partnership to launch ColoClear by Circle, the "First Colorec...

May 24, 2022 | Tuesday | News
INEX Innovate set to launch ovarian cancer detection test in Southeast Asian markets

Known as a pioneer in Asia's women's and foetal health industry, Singapore-based diagnostics developer, I...

May 11, 2022 | Wednesday | News
Japan-based Hitachi advances molecular diagnostics and precision medicine

Hitachi High-Tech Corporation, headquartered in Tokyo, Japan, has entered into a strategic partnership with In...

May 10, 2022 | Tuesday | News
KYAN Therapeutics, Curie Oncology offer personalised cancer test in Singapore

KYAN Therapeutics (a Delaware Corporation headquartered in Singapore) teams up with Curie Oncology to offer its novel an...

May 10, 2022 | Tuesday | News
Taiwan's iXensor receives strategic investment to expand mobile health biz globally

Taiwan's iXensor, the pioneer of mobile health, has announced that Rohto Pharmaceutical Co., Ltd, a multinational pharma...

April 28, 2022 | Thursday | News